AngioDynamics, Inc.
ANGO
$10.36
$0.383.81%
NASDAQ
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 79.43M | 75.71M | 80.16M | 72.00M | 72.85M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 79.43M | 75.71M | 80.16M | 72.00M | 72.85M |
| Cost of Revenue | 34.65M | 33.85M | 37.94M | 33.15M | 32.94M |
| Gross Profit | 44.78M | 41.86M | 42.22M | 38.86M | 39.91M |
| SG&A Expenses | 37.00M | 40.78M | 36.76M | 36.08M | 36.07M |
| Depreciation & Amortization | 2.64M | 2.65M | 2.59M | 2.60M | 2.56M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 81.92M | 83.61M | 83.79M | 78.65M | 77.92M |
| Operating Income | -2.49M | -7.90M | -3.63M | -6.65M | -5.07M |
| Income Before Tax | -6.36M | -10.84M | -6.11M | -4.41M | -10.85M |
| Income Tax Expenses | -5.00K | 65.00K | -60.00K | -2.00K | -110.00K |
| Earnings from Continuing Operations | -6.35M | -10.90M | -6.05M | -4.41M | -10.74M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.35M | -10.90M | -6.05M | -4.41M | -10.74M |
| EBIT | -2.49M | -7.90M | -3.63M | -6.65M | -5.07M |
| EBITDA | 3.26M | -1.88M | -1.20M | -329.00K | 1.79M |
| EPS Basic | -0.15 | -0.26 | -0.15 | -0.11 | -0.26 |
| Normalized Basic EPS | -0.04 | -0.12 | -0.06 | -0.02 | -0.07 |
| EPS Diluted | -0.15 | -0.26 | -0.15 | -0.11 | -0.26 |
| Normalized Diluted EPS | -0.04 | -0.12 | -0.06 | -0.02 | -0.07 |
| Average Basic Shares Outstanding | 41.54M | 41.17M | 40.98M | 40.85M | 40.92M |
| Average Diluted Shares Outstanding | 41.54M | 41.17M | 40.98M | 40.85M | 40.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |